These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2682963)

  • 1. Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo.
    Johnson RC
    Rev Infect Dis; 1989; 11 Suppl 6():S1505-10. PubMed ID: 2682963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values of diagnostic tests for the various species of spirochetes.
    Eldin C; Jaulhac B; Mediannikov O; Arzouni JP; Raoult D
    Med Mal Infect; 2019 Mar; 49(2):102-111. PubMed ID: 30765286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo susceptibility of Borrelia burgdorferi.
    Mursic VP; Wilske B; Schierz G; Holmburger M; Süss E
    Eur J Clin Microbiol; 1987 Aug; 6(4):424-6. PubMed ID: 3665899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum.
    Sambri V; Marangoni A; Giacani L; Gennaro R; Murgia R; Cevenini R; Cinco M
    J Antimicrob Chemother; 2002 Dec; 50(6):895-902. PubMed ID: 12461010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
    Baradaran-Dilmaghani R; Stanek G
    Infection; 1996; 24(1):60-3. PubMed ID: 8852472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic selective markers and spirochete genetics.
    Hardham JM; Rosey EL
    J Mol Microbiol Biotechnol; 2000 Oct; 2(4):425-32. PubMed ID: 11075914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro.
    Murgia R; Cinco M
    New Microbiol; 2001 Apr; 24(2):193-6. PubMed ID: 11346304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of third-generation cephalosporins. Spirochetes.
    Luft B; Mariuz P
    Hosp Pract (Off Ed); 1991; 26 Suppl 4():34-9; discussion 53-4. PubMed ID: 1918214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation in spirochetes.
    Indest KJ; Ramamoorthy R; Philipp MT
    J Mol Microbiol Biotechnol; 2000 Oct; 2(4):473-81. PubMed ID: 11075920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
    Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells.
    Marangoni A; Aldini R; Sambri V; Giacani L; Di Leo K; Cevenini R
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):187-91. PubMed ID: 15039093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro susceptibility of Borrelia burgdorferi and Borrelia hermsii to ten antimicrobial agents.
    Sambri V; Massaria F; Cevenini R; La Placa M
    J Chemother; 1990 Dec; 2(6):348-50. PubMed ID: 2093104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
    Henneberg JP; Neubert U
    Orv Hetil; 2002 May; 143(21):1195-8. PubMed ID: 12073540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain.
    De Koning J; Bosma RB; Hoogkamp-Korstanje JA
    J Med Microbiol; 1987 May; 23(3):261-7. PubMed ID: 2438410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans.
    Berger BW; Kaplan MH; Rothenberg IR; Barbour AG
    J Am Acad Dermatol; 1985 Sep; 13(3):444-9. PubMed ID: 3902917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin.
    Brouqui P; Badiaga S; Raoult D
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1552-4. PubMed ID: 8726038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
    Dever LL; Jorgensen JH; Barbour AG
    J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsyphilitic spirochetosis in second-trimester fetuses.
    Abramowsky C; Beyer-Patterson P; Cortinas E
    Pediatr Pathol; 1991; 11(6):827-38. PubMed ID: 1775399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.
    Johnson RC; Kodner C; Russell M
    Antimicrob Agents Chemother; 1987 Feb; 31(2):164-7. PubMed ID: 3566246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.